Resources

Filter by

October 31, 2024
Blog

Industry Shifts: A Closer Look at Recent CMS & J&J Announcements

Contracts & Pricing

September 4, 2024
Blog

$35 Patient Out-of-Pocket Strategy: Impacts on Prescription Drug Affordability & Implications for Pharma Manufacturers

Contracts & Pricing

September 4, 2024
Blog

Key Developments in Pharmaceutical Pricing Regulations

Contracts & Pricing

August 29, 2024
Blog

Industry Updates, Biosimilar Barriers, & the Impact of IRA Medicare Drug Price Negotiations

Market Access

July 30, 2024
Blog

The 340B Saga, New Orphan Drug Exclusion Criteria, & Drug Shortages Challenges the US Healthcare System

340B

June 28, 2024
Blog

States Influence Drug Pricing & Access, Specialty Pharmacies Evolve to Accommodate Cell & Gene Therapies, & Walgreens Enters the CGT Arena

Market Access

June 13, 2024
Blog

The Wild Ride of Medicare Part D Payer Challenges on Expenditures & Concessions

Contracts & Pricing

May 30, 2024
Blog

IRA Part D Redesign, New Gene Therapies Give Hope for Patients, & Updates on Regeneron Case

Market Access

April 24, 2024
Blog

Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert, & the Latest in Sustain Act 340B

Contracts & Pricing

April 4, 2024
Blog

The Top 10 Market Access Challenges

Market Access

March 22, 2024
Blog

FDA Approves Florida Drug Imports from Canada, GLP-1 Market Dilemma, & Illinois Pharma Price Gouging Law Challenged Recap

Contracts & Pricing

February 20, 2024
Blog

Navigating the Complexities of Biopharma/Pharma Net Revenue Forecasting

Gross-to-Net